GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vanta Bioscience Ltd (BOM:540729) » Definitions » YoY EPS Growth

Vanta Bioscience (BOM:540729) YoY EPS Growth : -285.88% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vanta Bioscience YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Vanta Bioscience's YoY EPS Growth for the quarter that ended in Sep. 2024 was -285.88%.

Vanta Bioscience's Earnings per Share (Diluted) for the six months ended in Sep. 2024 was ₹-3.28.

Vanta Bioscience YoY EPS Growth Historical Data

The historical data trend for Vanta Bioscience's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanta Bioscience YoY EPS Growth Chart

Vanta Bioscience Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial 44.55 -55.35 -80.28 -7,435.71 64.26

Vanta Bioscience Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13,633.33 -5,745.45 79.06 54.59 -285.88

Vanta Bioscience YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Vanta Bioscience's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(-3.67--10.27)/ | -10.27 |
=64.26 %

Vanta Bioscience's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(-3.28--0.85)/ | -0.85 |
=-285.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vanta Bioscience YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Vanta Bioscience's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Vanta Bioscience Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vanta Bioscience Ltd (BOM:540729) » Definitions » YoY EPS Growth
Comparable Companies
BOM:544220 BOM:542918 BOM:541299 BOM:526504 NSE:NIDAN BOM:539267 BOM:526301 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH XPAR:BIM
Traded in Other Exchanges
N/A
Address
No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003
Website
https://www.vantabio.com
Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.

Vanta Bioscience Headlines

No Headlines